On September 12, Dr. Ge Zhang, the Deputy Director of Institute for Advancing Translational Medicine in Bone & Joint Diseases (TMBJ), was invited to attend the “Canton Nucleic Acids Forum” to give an academic presentation on “Therapeutically Targeting miR-214 in osteogenic cells promotes boneformation in mice with established osteoporosis induced by ovariectomy”.

The forum was sponsored by Guangzhou Ribo Bio Limited Company. More than 300 experts from different countries attended the meeting and discussed the recent development and research focus of miRNA.

Dr. Zhang in the lecture